During the past decade, New Discovery, LLC conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "New Discovery, LLC" are "HBV" (2 trials), "Chronic HBV Infection" (1 trials), "Chronic HIV Infection" (1 trials), "Chronic Hepatitis B" (1 trials) and "Hepatitis C, Chronic" (1 trials). Many other conditions were trialed in "New Discovery, LLC" in a lesser frequency.

Most popular intervention types in "New Discovery, LLC" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "TAF" (2 trials), "TAF Placebo" (2 trials), "TDF" (2 trials), "TDF Placebo" (2 trials) and "ABI-H2158" (1 trials). Other intervention names were less common.

The vast majority of trials in "New Discovery, LLC" are 4 trials for "All" genders.

Currently, there are NaN active trials in "New Discovery, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in New Discovery, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in New Discovery, LLC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".